World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
16367
World Ranking
2240
National Ranking
86

Overview

Kenji Okuda is affiliated with Yokohama City University in Japan, contributing to fields primarily centered on medicine and biochemistry, genetics, and molecular biology. Their research encompasses multiple specialized subfields including infectious diseases, molecular biology, genetics, epidemiology, and biomedical engineering.

The main research topics explored by Kenji Okuda include SARS-CoV-2 and COVID-19 research, SARS-CoV-2 detection and testing, virus-based gene therapy research, biosensors and analytical detection, RNA interference and gene delivery, viral gastroenteritis research and epidemiology, and studies on animal virus infections.

Kenji Okuda's recent published papers cover a range of subjects in virology and immunology. Selected works include:

  • New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates, 2020, Vaccine
  • A rapid screening assay for L452R and T478K spike mutations in SARS-CoV-2 Delta variant using high-resolution melting analysis, 2021, The Journal of Toxicological Sciences
  • Current Vaccine Platforms in Enhancing T-Cell Response, 2022, Vaccines
  • The human papillomavirus E6 protein targets apoptosis-inducing factor (AIF) for degradation, 2020, Scientific Reports
  • Clinical Application of Adenovirus (AdV): A Comprehensive Review, 2024, Viruses

Frequent collaborators of Kenji Okuda include Masaru Shimada, Nobuhisa Mizuki, Akira Aoki, Hirokazu Adachi, and Yoko Mori, each contributing to multiple joint publications. This network highlights collaborative work predominantly within virology and immunological research.

Kenji Okuda's research outputs are often published in specific scientific journals, particularly Vaccine, Viruses, Vaccines, The Journal of Toxicological Sciences, and Scientific Reports, indicating a focus on infectious disease, immunology, and molecular biology communities.

Best Publications

  • NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene.

    A Ueda;K Okuda;S Ohno;A Shirai

  • The Atg5 Atg12 conjugate associates with innate antiviral immune responses.

    Nao Jounai;Fumihiko Takeshita;Kouji Kobiyama;Asako Sawano

  • Infection with Hepatitis GB Virus C in Patients on Maintenance Hemodialysis

    Kazuo Masuko;Takehiro Mitsui;Keiko Iwano;Chikao Yamazaki

  • Developments in Viral Vector-Based Vaccines.

    Takehiro Ura;Kenji Okuda;Masaru Shimada

  • Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.

    E. Okada;S. Sasaki;N. Ishii;I. Aoki

  • The Timing of GM-CSF Expression Plasmid Administration Influences the Th1/Th2 Response Induced by an HIV-1-Specific DNA Vaccine

    Ken-ichi Kusakabe;Ke-Qin Xin;Hidenori Katoh;Kaharu Sumino

  • Functional Expression of the CXC-Chemokine Receptor-4/ Fusin on Mouse Microglial Cells and Astrocytes'

    S Tanabe;M Heesen;I Yoshizawa;M A Berman

  • Do DNA Vaccines Induce Autoimmune Disease

    Gil Mor;Manav Singla;Alfred D. Steinberg;Stephen L. Hoffman

  • Induction of Systemic and Mucosal Immune Responses to Human Immunodeficiency Virus Type 1 by a DNA Vaccine Formulated with QS-21 Saponin Adjuvant via Intramuscular and Intranasal Routes

    Shin Sasaki;Kaharu Sumino;Kenji Hamajima;Jun Fukushima

  • Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env.

    Ke-Qin Xin;Yuka Hoshino;Yoshihiko Toda;Shizunobu Igimi

  • Enhancement of cell-mediated immunity against HIV-1 induced by coinnoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12.

    T. Tsuji;K. Hamajima;J. Fukushima;K.-Q. Xin

  • Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene.

    Kenji Okuda;Atsushi Ihata;Setsuko Watabe;Eiichi Okada

  • Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine

    Yoshitsugu Kojima;Ke-Qin Xin;Takaaki Ooki;Kenji Hamajima

  • Immunoglobulin G response to subgingival gram-negative bacteria in human subjects.

    Y Naito;K Okuda;I Takazoe

  • Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate.

    Hiroki Bukawa;Ken-Ichiro Sekigawa;Kenji Hamajima;Jun Fukushima

  • IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine.

    Ke-Qin Xin;Kenji Hamajima;Shin Sasaki;Takashi Tsuji

  • HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody.

    S. Toda;N. Ishii;E. Okada;K.-I. Kusakabe

  • Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1.

    Norihisa Ishii;Jun Fukushima;Tamiko Kaneko;Eiichi Okada

  • Detection of Treponema denticola in Atherosclerotic Lesions

    Katsuji Okuda;Kazuyuki Ishihara;Taneaki Nakagawa;Akihiko Hirayama

  • Distribution of Porphyromonas gingivalis and Treponema denticola in human subgingival plaque at different periodontal pocket depths examined by immunohistochemical methods

    T. Kigure;A. Saito;K. Seida;S. Yamada

Frequent Co-Authors

Norihisa Ishii
Norihisa Ishii National Institutes of Biomedical Innovation, Health and Nutrition
Dennis M. Klinman
Dennis M. Klinman National Institutes of Health
Britta Wahren
Britta Wahren Karolinska Institute
Martin E. Dorf
Martin E. Dorf Harvard University
Hiroaki Mizukami
Hiroaki Mizukami Jichi Medical University
Hiroyuki Mizuguchi
Hiroyuki Mizuguchi Osaka University
Keiya Ozawa
Keiya Ozawa Jichi Medical University
Jorma Hinkula
Jorma Hinkula Linköping University
Naoki Yamamoto
Naoki Yamamoto Kyoto University
Nobuhisa Mizuki
Nobuhisa Mizuki Yokohama City University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many students transition into nursing to apply immunological knowledge directly to patient care. Programs like 12-month accelerated nursing programs online for non nurses offer fast-tracked options for individuals without a nursing background, making it easier to enter the field quickly.

If gaining admission is a concern, exploring the easiest accelerated nursing programs to get into can help you start your studies sooner. These programs balance rigorous training with more accessible admission criteria, ideal for non-traditional students.

For those seeking practical nursing roles, considering the best easiest lpn programs to get into can provide a streamlined path to licensure and patient care roles that benefit from immunological insights.

Advanced practice is another option, with easiest online nurse practitioner programs designed for professionals aiming to expand their clinical scope. These programs often feature flexible online formats, catering to working students pursuing specialized careers where immunology plays a critical role.

Best Scientists Citing Kenji Okuda

Trending Scientists

Recently Published Articles